Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 377

1.

Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.

Zelini P, Fornara C, Furione M, Sarasini A, Klemens J, Arossa A, Spinillo A, Gerna G, Lilleri D.

J Clin Virol. 2019 Sep 13;120:38-43. doi: 10.1016/j.jcv.2019.09.006. [Epub ahead of print]

PMID:
31546089
2.

Brief molecular diagnostic criteria for human cytomegalovirus infection/disease.

Gerna G, Baldanti F.

Expert Rev Mol Diagn. 2019 Sep;19(9):773-775. doi: 10.1080/14737159.2019.1657010. Epub 2019 Aug 22. No abstract available.

PMID:
31418603
3.

Human Cytomegalovirus Cell Tropism and Host Cell Receptors.

Gerna G, Kabanova A, Lilleri D.

Vaccines (Basel). 2019 Jul 22;7(3). pii: E70. doi: 10.3390/vaccines7030070. Review.

4.

An overview of letermovir: a cytomegalovirus prophylactic option.

Gerna G, Lilleri D, Baldanti F.

Expert Opin Pharmacother. 2019 Aug;20(12):1429-1438. doi: 10.1080/14656566.2019.1637418. Epub 2019 Jul 8.

PMID:
31282759
5.

Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss.

Suárez NM, Wilkie GS, Hage E, Camiolo S, Holton M, Hughes J, Maabar M, Vattipally SB, Dhingra A, Gompels UA, Wilkinson GWG, Baldanti F, Furione M, Lilleri D, Arossa A, Ganzenmueller T, Gerna G, Hubáček P, Schulz TF, Wolf D, Zavattoni M, Davison AJ.

J Infect Dis. 2019 Jul 31;220(5):781-791. doi: 10.1093/infdis/jiz208.

6.

Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.

Gerna G, Lilleri D.

New Microbiol. 2019 Jan;42(1):1-20. Epub 2019 Jan 21. Review.

7.
8.
9.

Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission.

Mele F, Fornara C, Jarrossay D, Furione M, Arossa A, Spinillo A, Lanzavecchia A, Gerna G, Sallusto F, Lilleri D.

PLoS One. 2017 Nov 7;12(11):e0187731. doi: 10.1371/journal.pone.0187731. eCollection 2017.

10.

The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development.

Gerna G, Revello MG, Baldanti F, Percivalle E, Lilleri D.

J Gen Virol. 2017 Sep;98(9):2215-2234. doi: 10.1099/jgv.0.000882. Epub 2017 Aug 15. Review.

PMID:
28809151
11.

Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy.

Lilleri D, Gerna G.

Rev Med Virol. 2017 Mar;27(2). doi: 10.1002/rmv.1921. Epub 2016 Dec 23. Review.

PMID:
28008685
12.

Corrigendum to Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.

Bruno F, Fornara C, Zelini P, Furione M, Carrara E, Scaramuzzi L, Cane I, Mele F, Sallusto F, Lilleri D, Gerna G.

J Gen Virol. 2016 Oct;97(10):2798. doi: 10.1099/jgv.0.000615. No abstract available.

PMID:
27902353
13.

Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.

Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, Lilleri D.

New Microbiol. 2016 Oct;39(4):247-258. Epub 2016 Sep 13.

14.

Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.

Lilleri D, Gerna G.

Immunotherapy. 2016 Sep;8(9):1135-49. doi: 10.2217/imt-2015-0028. Review.

PMID:
27485084
15.

Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy.

Lilleri D, Gerna G, Furione M, Zavattoni M, Spinillo A.

J Clin Virol. 2016 Aug;81:16-24. doi: 10.1016/j.jcv.2016.05.007. Epub 2016 May 17.

PMID:
27289427
16.
17.

Follicular helper T-cells and virus-specific antibody response in primary and reactivated human cytomegalovirus infections of the immunocompetent and immunocompromised transplant patients.

Bruno F, Fornara C, Zelini P, Furione M, Carrara E, Scaramuzzi L, Cane I, Mele F, Sallusto F, Lilleri D, Gerna G.

J Gen Virol. 2016 Aug;97(8):1928-41. doi: 10.1099/jgv.0.000488. Epub 2016 Apr 25. Erratum in: J Gen Virol. 2016 Oct;97(10):2798.

PMID:
27113912
19.

Prevention of Primary Cytomegalovirus Infection in Pregnancy.

Revello MG, Tibaldi C, Masuelli G, Frisina V, Sacchi A, Furione M, Arossa A, Spinillo A, Klersy C, Ceccarelli M, Gerna G, Todros T; CCPE Study Group.

EBioMedicine. 2015 Aug 6;2(9):1205-10. doi: 10.1016/j.ebiom.2015.08.003. eCollection 2015 Sep.

20.

Reconstitution of Human Cytomegalovirus-Specific CD4+ T Cells is Critical for Control of Virus Reactivation in Hematopoietic Stem Cell Transplant Recipients but Does Not Prevent Organ Infection.

Gabanti E, Lilleri D, Ripamonti F, Bruno F, Zelini P, Furione M, Colombo AA, Alessandrino EP, Gerna G.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2192-2202. doi: 10.1016/j.bbmt.2015.08.002. Epub 2015 Aug 8.

21.

Sequencing and analysis of globally obtained human respiratory syncytial virus A and B genomes.

Bose ME, He J, Shrivastava S, Nelson MI, Bera J, Halpin RA, Town CD, Lorenzi HA, Noyola DE, Falcone V, Gerna G, De Beenhouwer H, Videla C, Kok T, Venter M, Williams JV, Henrickson KJ.

PLoS One. 2015 Mar 20;10(3):e0120098. doi: 10.1371/journal.pone.0120098. eCollection 2015.

22.

Primary human cytomegalovirus infections: kinetics of ELISA-IgG and neutralizing antibody in pauci/asymptomatic pregnant women vs symptomatic non-pregnant subjects.

Fornara C, Furione M, Lilleri D, Cane I, Revello MG, Zavattoni M, Gerna G.

J Clin Virol. 2015 Mar;64:45-51. doi: 10.1016/j.jcv.2015.01.004. Epub 2015 Jan 6.

PMID:
25728078
23.

Cytomegalovirus DNAemia in pregnant women.

Revello MG, Furione M, Rognoni V, Arossa A, Gerna G.

J Clin Virol. 2014 Dec;61(4):590-2. doi: 10.1016/j.jcv.2014.10.002. Epub 2014 Oct 18.

PMID:
25457128
24.

Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies.

Kabanova A, Perez L, Lilleri D, Marcandalli J, Agatic G, Becattini S, Preite S, Fuschillo D, Percivalle E, Sallusto F, Gerna G, Corti D, Lanzavecchia A.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):17965-70. doi: 10.1073/pnas.1415310111. Epub 2014 Dec 1.

25.

Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host.

Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, Furione M, Revello MG.

J Gen Virol. 2015 Feb;96(Pt 2):360-9. doi: 10.1099/vir.0.070441-0. Epub 2014 Oct 14.

PMID:
25316796
26.

Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.

Gabanti E, Bruno F, Fornara C, Bernuzzi S, Lilleri D, Gerna G.

J Clin Immunol. 2014 Nov;34(8):999-1008. doi: 10.1007/s10875-014-0093-5. Epub 2014 Sep 18.

PMID:
25231588
27.

Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.

Gabanti E, Bruno F, Lilleri D, Fornara C, Zelini P, Cane I, Migotto C, Sarchi E, Furione M, Gerna G.

PLoS One. 2014 Aug 28;9(8):e106044. doi: 10.1371/journal.pone.0106044. eCollection 2014.

28.

Hyperimmune globulin to prevent congenital CMV infection.

Spinillo A, Gerna G.

N Engl J Med. 2014 Jun 26;370(26):2544-5. doi: 10.1056/NEJMc1405377. No abstract available.

PMID:
24963582
29.

A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.

Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C, Gerna G; CHIP Study Group.

N Engl J Med. 2014 Apr 3;370(14):1316-26. doi: 10.1056/NEJMoa1310214.

30.

Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.

Lilleri D, Gerna G, Bruno F, Draghi P, Gabanti E, Fornara C, Meloni F.

New Microbiol. 2013 Jul;36(3):267-77. Epub 2013 Jun 30.

31.

Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus.

Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, Revello MG.

J Med Virol. 2013 Nov;85(11):1960-7. doi: 10.1002/jmv.23691. Epub 2013 Jul 25.

PMID:
23893782
32.

Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gH/gL/pUL128-130-131 complex during primary infection.

Lilleri D, Kabanova A, Revello MG, Percivalle E, Sarasini A, Genini E, Sallusto F, Lanzavecchia A, Corti D, Gerna G.

PLoS One. 2013;8(3):e59863. doi: 10.1371/journal.pone.0059863. Epub 2013 Mar 29.

33.

Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.

Lilleri D, Gerna G, Zelini P, Chiesa A, Rognoni V, Mastronuzzi A, Giorgiani G, Zecca M, Locatelli F.

PLoS One. 2012;7(7):e41648. doi: 10.1371/journal.pone.0041648. Epub 2012 Jul 25.

34.

Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients.

Gerna G, Lilleri D, Furione M, Castiglioni B, Meloni F, Rampino T, Agozzino M, Arbustini E.

New Microbiol. 2012 Jul;35(3):279-87. Epub 2012 Jun 30.

35.

Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.

Lilleri D, Kabanova A, Lanzavecchia A, Gerna G.

J Clin Immunol. 2012 Dec;32(6):1324-31. doi: 10.1007/s10875-012-9739-3. Epub 2012 Jul 27.

PMID:
22836657
36.

Human rhinovirus and human respiratory enterovirus (EV68 and EV104) infections in hospitalized patients in Italy, 2008-2009.

Piralla A, Lilleri D, Sarasini A, Marchi A, Zecca M, Stronati M, Baldanti F, Gerna G.

Diagn Microbiol Infect Dis. 2012 Jun;73(2):162-7. doi: 10.1016/j.diagmicrobio.2012.02.019. Epub 2012 Apr 10.

PMID:
22494556
37.

Infections and organ transplantation: new challenges for prevention and treatment--a colloquium.

Grossi PA, Costa AN, Fehily D, Blumberg EA, Kuehnert MJ, Fishman JA, Ison MG, Lattes R, Kotton CN, Lilleri D, Kabanova A, Lanzavecchia A, Gerna G, Razonable RR, Comoli P, Zecca M, Basso S, Ginevri F, Grossi A, Schena FP, Rimola A, Burra P, De Martin E, Rodriguez-Castro KI, Fagiuoli S, Pasulo L, Bruno R, Andreone P, Loggi E, Arena F, Rossolini GM, Sganga G, Cozza V.

Transplantation. 2012 Mar 15;93(5 Suppl):S4-S39. doi: 10.1097/TP.0b013e3182481347. No abstract available.

PMID:
22374265
38.

Endothelial cells and CMV dissemination.

Gerna G.

Future Microbiol. 2012 Apr;7(4):441-4. doi: 10.2217/fmb.12.12.

PMID:
22439720
39.

Human parechovirus infections in patients admitted to hospital in Northern Italy, 2008-2010.

Piralla A, Furione M, Rovida F, Marchi A, Stronati M, Gerna G, Baldanti F.

J Med Virol. 2012 Apr;84(4):686-90. doi: 10.1002/jmv.23197.

PMID:
22337310
40.

Kinetics of effector functions and phenotype of virus-specific and γδ T lymphocytes in primary human cytomegalovirus infection during pregnancy.

Fornara C, Lilleri D, Revello MG, Furione M, Zavattoni M, Lenta E, Gerna G.

J Clin Immunol. 2011 Dec;31(6):1054-64. doi: 10.1007/s10875-011-9577-8. Epub 2011 Aug 17.

PMID:
21847524
41.

Heart rate and cardiac allograft vasculopathy in heart transplant recipients.

Olmetti F, Pinna GD, Maestri R, D'Armini A, Pellegrini C, Viganò M, Lilleri D, Gerna G, Febo O, La Rovere MT.

J Heart Lung Transplant. 2011 Dec;30(12):1368-73. doi: 10.1016/j.healun.2011.07.009. Epub 2011 Aug 15.

PMID:
21840733
42.

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

Gerna G, Lilleri D, Chiesa A, Zelini P, Furione M, Comolli G, Pellegrini C, Sarchi E, Migotto C, Bonora MR, Meloni F, Arbustini E.

Am J Transplant. 2011 Nov;11(11):2463-71. doi: 10.1111/j.1600-6143.2011.03636.x. Epub 2011 Aug 9.

43.

Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections.

Genini E, Percivalle E, Sarasini A, Revello MG, Baldanti F, Gerna G.

J Clin Virol. 2011 Oct;52(2):113-8. doi: 10.1016/j.jcv.2011.06.018. Epub 2011 Aug 4.

PMID:
21820353
44.
45.

Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience.

Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, Rognoni V, Spinillo A, Gerna G.

J Clin Virol. 2011 Apr;50(4):303-7. doi: 10.1016/j.jcv.2010.12.012. Epub 2011 Feb 1.

PMID:
21277825
46.

Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood.

Fabbri E, Revello MG, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Rustico M, Nicolini U, Ferrazzi E, Gerna G.

BJOG. 2011 Mar;118(4):448-56. doi: 10.1111/j.1471-0528.2010.02822.x. Epub 2010 Dec 24.

47.
48.

Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays.

Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G.

J Clin Virol. 2010 Aug;48(4):255-9. doi: 10.1016/j.jcv.2010.05.004. Epub 2010 Jun 18.

PMID:
20561816
49.

Enterovirus genotype EV-104 in humans, Italy, 2008-2009.

Piralla A, Rovida F, Baldanti F, Gerna G.

Emerg Infect Dis. 2010 Jun;16(6):1018-21. doi: 10.3201/eid1606.091533.

50.

Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.

Zelini P, Lilleri D, Comolli G, Rognoni V, Chiesa A, Fornara C, Locatelli F, Meloni F, Gerna G.

Clin Immunol. 2010 Aug;136(2):269-81. doi: 10.1016/j.clim.2010.04.008. Epub 2010 May 20.

PMID:
20493777

Supplemental Content

Support Center